Judge Approves $1.15M Settlement In Stock Drop Suit Against Drug Maker

Mealey's (November 26, 2019, 4:53 PM EST) -- LOS ANGELES — A federal judge in California on Nov. 19 granted final approval of a $1.15 million securities class action settlement against a drug maker, certain of its current and former officers and directors and others over their alleged involvement in an illegal stock-pumping scheme (Arthur Kaye IRA FCC, et al. v. ImmunoCellular Therapeutics Ltd., et al., No. 17-3250, C.D. Calif., 2019 U.S. Dist. LEXIS 201657)....

Attached Documents

Related Sections